Shanghai Fosun Pharmaceutical (Group) Co has a quick ratio of 0.76. It indicates that the company cannot currently fully pay back its current liabilities.
STU:08HH's Quick Ratio is ranked worse than 78.01% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs STU:08HH: 0.76
Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Shanghai Fosun Pharmaceutical (Group) Co Quick Ratio Related Terms
Shanghai Fosun Pharmaceutical (Group) Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Fosun Pharmaceutical (Group) Co Quick Ratio Chart
Shanghai Fosun Pharmaceutical (Group) Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Fosun Pharmaceutical (Group) Co Quick Ratio vs Drug Manufacturers Industry
Shanghai Fosun Pharmaceutical (Group) Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) has a Quick Ratio of 0.76 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shanghai Fosun Pharmaceutical (Group) Co and its competitors. This is near median its historical median of 0.80. Over the past decade, Shanghai Fosun Pharmaceutical (Group) Co's Quick Ratio has ranged from 0.61 to 1.29. According to the industry distribution chart, Shanghai Fosun Pharmaceutical (Group) Co ranks #777 out of 996 companies in the Drug Manufacturers industry, placing it in the top 78%.
Is Shanghai Fosun Pharmaceutical (Group) Co's Quick Ratio too high?
Shanghai Fosun Pharmaceutical (Group) Co's current Quick Ratio of 0.76 is near median its 10-year median of 0.80. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 1.29. The Drug Manufacturers industry median Quick Ratio is 1.45. Shanghai Fosun Pharmaceutical (Group) Co's value of 0.76 is 47.6% below this industry median. Based on the distribution chart, Shanghai Fosun Pharmaceutical (Group) Co ranks #777 out of 996 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai Fosun Pharmaceutical (Group) Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Fosun Pharmaceutical (Group) Co's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Fosun Pharmaceutical (Group) Co ranks #777 out of 996 companies for Quick Ratio. This places Shanghai Fosun Pharmaceutical (Group) Co in the lower half of its industry. The industry median Quick Ratio is 1.45. Shanghai Fosun Pharmaceutical (Group) Co's value of 0.76 is 47.6% below this benchmark. Historically, Shanghai Fosun Pharmaceutical (Group) Co's own Quick Ratio has ranged from 0.61 to 1.29 over the past decade. While the company's 10-year median is 0.80 vs. the industry median of 1.45, Shanghai Fosun Pharmaceutical (Group) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Fosun Pharmaceutical (Group) Co's current Quick Ratio of 0.76 is 47.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shanghai Fosun Pharmaceutical (Group) Co and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Fosun Pharmaceutical (Group) Co's current Quick Ratio is 0.76, which is near median its own 10-year median of 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Fosun Pharmaceutical (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.07, compared to a current price of €1.78 — trading 13.9% below its estimated fair value. The current Quick Ratio is 0.76, which is near median its 10-year median of 0.80 and 47.6% below the Drug Manufacturers industry median of 1.45. Shanghai Fosun Pharmaceutical (Group) Co's overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH), the current Quick Ratio is 0.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Fosun Pharmaceutical (Group) Co stock appears to be undervalued.
The current stock price of €1.78 is trading 13.9% below its estimated GF Value™ of €2.07.
GuruFocus considers Shanghai Fosun Pharmaceutical (Group) Co to be Modestly Undervalued.
Key valuation signals for STU:08HH:
Quick Ratio: 0.76 (near median its 10-year median of 0.80)
GF Value™: €2.07 vs. price of €1.78 (13.9% below fair value)
Industry Position: 47.6% below the Drug Manufacturers median (#777 of 996)
No single metric tells the full story. See the STU:08HH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Fosun Pharmaceutical (Group) Co Business Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
73GF Score
Get the complete analysis for STU:08HH
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:08HH has been successfully added to your 
